Exact Mass: 463.0481094

Exact Mass Matches: 463.0481094

Found 63 metabolites which its exact mass value is equals to given mass value 463.0481094, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Adenylsuccinic acid

(2S)-2-({9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-9H-purin-6-yl}amino)butanedioic acid

C14H18N5O11P (463.0740408)


Adenylsuccinic acid, also known as adenylosuccinate, succinyladenosine or aspartyl adenylate, belongs to the class of organic compounds known as purine ribonucleoside monophosphates. These are nucleotides consisting of a purine base linked to a ribose to which one monophosphate group is attached. Adenylsuccinic acid is found in all living organisms, ranging from bacteria to plants to animals. Adenylsuccinic acid is an important intermediate in the de novo purine biosynthesis pathway. Specifically, adenylsuccinic acid is an intermediate in the interconversion of purine nucleotides inosine monophosphate (IMP) and adenosine monophosphate (AMP). The enzyme adenylosuccinate synthase carries out the reaction by the addition of aspartate to IMP. This reaction requires the input of energy from a phosphoanhydride bond in the form of guanosine triphosphate (GTP). Adenylsuccinic acid is a substrate least one other important metabolic reaction in purine biosynthesis. In particular, adenylsuccinic acid can be converted into fumaric acid through its interaction with the enzyme known as adenylosuccinate lyase (or adenylosuccinase). Adenylosuccinate lyase deficiency, is a rare autosomal recessive metabolic disorder characterized by the appearance of succinylaminoimidazolecarboxamide riboside (SAICA riboside) and adenylsuccinic acid in cerebrospinal fluid and urine (PMID: 8412002). Adenylosuccinate lyase deficiency presents with varying degrees of psychomotor retardation, autism, muscle wasting, and epilepsy. The exact cause of the symptoms is unknown, but possibilities include not enough purine nucleotide synthesis for cell replication, malfunctioning of the purine nucleotide cycle, and a buildup of substrates to toxic levels. Adenylsuccinic acid is a substrate of the enzyme adenylosuccinase [EC 4.3.2.2] in purine metabolism pathway. The accumulation of adenylsuccinic acid in body fluids occurs due to a deficiency of adenylosuccinase. (KEGG; PMID 8412002) [HMDB] D018377 - Neurotransmitter Agents > D018846 - Excitatory Amino Acids KEIO_ID A037; [MS2] KO008839 KEIO_ID A037; [MS3] KO008840 KEIO_ID A037

   

L 735821

(E)-3-(2,4-dichlorophenyl)-N-[(3R)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]prop-2-enamide

C25H19Cl2N3O2 (463.0854254)


D002317 - Cardiovascular Agents > D026902 - Potassium Channel Blockers D049990 - Membrane Transport Modulators

   

[(3S)-1-Azabicyclo[2.2.2]octan-3-yl] 2-hydroxy-2-(4-iodophenyl)-2-phenylacetate

[(3S)-1-Azabicyclo[2.2.2]octan-3-yl] 2-hydroxy-2-(4-iodophenyl)-2-phenylacetic acid

C21H22INO3 (463.06443720000004)


   

Adenylosuccinic acid

2-[(9-{3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl}-9H-purin-6-yl)amino]butanedioic acid

C14H18N5O11P (463.0740408)


   

6-Methylthio-3-oxohexyl glucosinolate

6-Methylthio-3-oxohexyl glucosinolate

C14H25NO10S3 (463.064055)


   
   

O1-Benzoyl-2-(4-{[3-chloro-5-(trifluoromethyl)-2-pyridyl]methoxy}phenyl)ethanehydroximamide

O1-Benzoyl-2-(4-{[3-chloro-5-(trifluoromethyl)-2-pyridyl]methoxy}phenyl)ethanehydroximamide

C22H17ClF3N3O3 (463.09104780000007)


   
   

Chondritinsulfate

(2S,3S,4S,5R,6R)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-sulfooxyoxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylicacid

C13H21NO15S (463.06318760000005)


   

2-METHOXYETHYL 2-(5-[2-CHLORO-4-(TRIFLUOROMETHYL)PHENOXY]-2-NITROPHENOXY)PROPANOATE

2-METHOXYETHYL 2-(5-[2-CHLORO-4-(TRIFLUOROMETHYL)PHENOXY]-2-NITROPHENOXY)PROPANOATE

C19H17ClF3NO7 (463.06455980000004)


   

N-(5-chloro-2-methylphenyl)-4-[(5-chloro-2-methylphenyl)azo]-3-hydroxynaphthalene-2-carboxamide

N-(5-chloro-2-methylphenyl)-4-[(5-chloro-2-methylphenyl)azo]-3-hydroxynaphthalene-2-carboxamide

C25H19Cl2N3O2 (463.0854254)


   

5-[4-benzoyl-2,3-bis[(6-diazonio-5-oxidonaphthalen-1-yl)sulfonyloxy]phenoxy]sulfonyl-2-diazonionaphthalen-1-olate

5-[4-benzoyl-2,3-bis[(6-diazonio-5-oxidonaphthalen-1-yl)sulfonyloxy]phenoxy]sulfonyl-2-diazonionaphthalen-1-olate

C23H15N2O7S+ (463.059994)


   

ammonium 2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9-hexadecafluorononan-1-oate

ammonium 2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9-hexadecafluorononan-1-oate

C9H5F16NO2 (463.0064782)


   

1H,1H,2H,2H-Perfluorodecylamine

1H,1H,2H,2H-Perfluorodecylamine

C10H6F17N (463.022876)


   

4-Iodo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]benzeneethanamine hydrochloride

4-Iodo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]benzeneethanamine hydrochloride

C18H23ClINO3 (463.04111480000006)


   

2-[N-(2-cyanoethyl)-4-[(2,6-dichloro-4-nitrophenyl)azo]-3-methylanilino]ethyl acetate

2-[N-(2-cyanoethyl)-4-[(2,6-dichloro-4-nitrophenyl)azo]-3-methylanilino]ethyl acetate

C20H19Cl2N5O4 (463.08140340000006)


   
   

[2-[(2-chlorophenyl)carbamoyl]-4-(2,4-difluorophenyl)phenyl] benzoate

[2-[(2-chlorophenyl)carbamoyl]-4-(2,4-difluorophenyl)phenyl] benzoate

C26H16ClF2NO3 (463.0786720000001)


   

[2-[(3-chlorophenyl)carbamoyl]-4-(2,4-difluorophenyl)phenyl] benzoate

[2-[(3-chlorophenyl)carbamoyl]-4-(2,4-difluorophenyl)phenyl] benzoate

C26H16ClF2NO3 (463.0786720000001)


   

[2-[(4-chlorophenyl)carbamoyl]-4-(2,4-difluorophenyl)phenyl] benzoate

[2-[(4-chlorophenyl)carbamoyl]-4-(2,4-difluorophenyl)phenyl] benzoate

C26H16ClF2NO3 (463.0786720000001)


   
   

N-(4-chloro-2-methylphenyl)-4-[(4-chloro-2-methylphenyl)azo]-3-hydroxynaphthalene-2-carboxamide

N-(4-chloro-2-methylphenyl)-4-[(4-chloro-2-methylphenyl)azo]-3-hydroxynaphthalene-2-carboxamide

C25H19Cl2N3O2 (463.0854254)


   
   

2-(3-BroMo-biphenyl-3-yl)-4,6-diphenyl-[1,3,5]triazine

2-(3-BroMo-biphenyl-3-yl)-4,6-diphenyl-[1,3,5]triazine

C27H18BrN3 (463.0684008)


   

2-(3-bromobiphenyl-4-yl)-4,6-diphenyl-1,3,5-triazine

2-(3-bromobiphenyl-4-yl)-4,6-diphenyl-1,3,5-triazine

C27H18BrN3 (463.0684008)


   

2-(3,4-Dihydroxyphenyl)-3-(beta-D-glucopyranuronosyloxy)-5,7-dihydroxy-1-benzopyrylium

2-(3,4-Dihydroxyphenyl)-3-(beta-D-glucopyranuronosyloxy)-5,7-dihydroxy-1-benzopyrylium

C21H19O12 (463.08764740000004)


   

beta-D-Mannopyranosyl azide 3,4,6-triacetate 2-(1,1,1-trifluoromethanesulfonate)

beta-D-Mannopyranosyl azide 3,4,6-triacetate 2-(1,1,1-trifluoromethanesulfonate)

C13H16F3N3O10S (463.0508472)


   

CHONDROITIN SULFATE SHARK CARTILAGE(RG)

CHONDROITIN SULFATE SHARK CARTILAGE(RG)

C13H21NO15S (463.06318760000005)


   

1-(diaminomethylidene)-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]urea; 2,4,6-trinitrophenol

1-(diaminomethylidene)-3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]urea; 2,4,6-trinitrophenol

C13H17N7O12 (463.0935162)


   
   

2,2:6,2-Terpyridine Platinum(Ii) Chloride

2,2:6,2-Terpyridine Platinum(Ii) Chloride

C15H11ClN3Pt+ (463.0289306)


   

N-[7-(3-Aminophenyl)-5-methoxy-1,3-benzoxazol-2-YL]-2,5-dichlorobenzenesulfonamide

N-[7-(3-Aminophenyl)-5-methoxy-1,3-benzoxazol-2-YL]-2,5-dichlorobenzenesulfonamide

C20H15Cl2N3O4S (463.01602900000006)


   

Aspartyl adenylate

Aspartyl adenylate

C14H18N5O11P (463.0740408)


D018377 - Neurotransmitter Agents > D018846 - Excitatory Amino Acids

   
   

1-S-[2-(4-hydroxy-1H-indol-3-yl)-N-(sulfooxy)ethanimidoyl]-1-thio-beta-D-glucopyranose

1-S-[2-(4-hydroxy-1H-indol-3-yl)-N-(sulfooxy)ethanimidoyl]-1-thio-beta-D-glucopyranose

C16H19N2O10S2- (463.0481094)


   

2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-3-olate

2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-3-olate

C21H19O12- (463.08764740000004)


   
   
   
   

6-Demethyl-chlortetracycline

6-Demethyl-chlortetracycline

C21H20ClN2O8- (463.090813)


   

(4S,4aS,5aS,6S,12aR)-2-carbamoyl-7-chloro-4-(dimethylazaniumyl)-6,10,12a-trihydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-1,11-diolate

(4S,4aS,5aS,6S,12aR)-2-carbamoyl-7-chloro-4-(dimethylazaniumyl)-6,10,12a-trihydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-1,11-diolate

C21H20ClN2O8- (463.090813)


   

4-Hydroxyindol-3-ylmethylglucosinolate

4-Hydroxyindol-3-ylmethylglucosinolate

C16H19N2O10S2- (463.0481094)


   

3-[4-[[[4-chloro-3-(trifluoromethyl)anilino]-oxomethyl]amino]phenoxy]-N-methylbenzamide

3-[4-[[[4-chloro-3-(trifluoromethyl)anilino]-oxomethyl]amino]phenoxy]-N-methylbenzamide

C22H17ClF3N3O3 (463.09104780000007)


   

3-[[4-(1,1,1,3,3,3-Hexafluoro-2-hydroxypropan-2-yl)phenyl]sulfamoyl]-2-thiophenecarboxylic acid methyl ester

3-[[4-(1,1,1,3,3,3-Hexafluoro-2-hydroxypropan-2-yl)phenyl]sulfamoyl]-2-thiophenecarboxylic acid methyl ester

C15H11F6NO5S2 (462.9982828)


   

9-(3-bromo-4-hydroxyphenyl)-10-phenyl-3,4,5,6,7,9-hexahydro-2H-acridine-1,8-dione

9-(3-bromo-4-hydroxyphenyl)-10-phenyl-3,4,5,6,7,9-hexahydro-2H-acridine-1,8-dione

C25H22BrNO3 (463.07829620000007)


   

N-(1,3-benzodioxol-5-yl)-2-[[4-(4-methoxyphenyl)-6-(trifluoromethyl)-2-pyrimidinyl]thio]acetamide

N-(1,3-benzodioxol-5-yl)-2-[[4-(4-methoxyphenyl)-6-(trifluoromethyl)-2-pyrimidinyl]thio]acetamide

C21H16F3N3O4S (463.08135720000007)


   
   
   

5-Acetamido-4-hydroxy-3-(phenyldiazenyl)naphthalene-2,7-disulfonate

5-Acetamido-4-hydroxy-3-(phenyldiazenyl)naphthalene-2,7-disulfonate

C18H13N3O8S2-2 (463.0144058)


   

4-amino-N-[2-[[5-bromo-2-[(2-fluorophenyl)methoxy]phenyl]methylamino]ethyl]-1,2,5-oxadiazole-3-carboxamide

4-amino-N-[2-[[5-bromo-2-[(2-fluorophenyl)methoxy]phenyl]methylamino]ethyl]-1,2,5-oxadiazole-3-carboxamide

C19H19BrFN5O3 (463.0655216)


   

(5R)-3-[bis(4-bromophenyl)methoxy]-8-methyl-8-azabicyclo[3.2.1]octane

(5R)-3-[bis(4-bromophenyl)methoxy]-8-methyl-8-azabicyclo[3.2.1]octane

C21H23Br2NO (463.01462680000003)


   

3,4,5-Trihydroxy-6-[2-hydroxy-5-(3,5,7-trihydroxychromenylium-2-yl)phenoxy]oxane-2-carboxylic acid

3,4,5-Trihydroxy-6-[2-hydroxy-5-(3,5,7-trihydroxychromenylium-2-yl)phenoxy]oxane-2-carboxylic acid

C21H19O12+ (463.08764740000004)


   

6-[2-(3,4-Dihydroxyphenyl)-3,5-dihydroxychromenylium-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

6-[2-(3,4-Dihydroxyphenyl)-3,5-dihydroxychromenylium-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C21H19O12+ (463.08764740000004)


   

delphinidin 3-O-beta-D-galactoside(1-)

delphinidin 3-O-beta-D-galactoside(1-)

C21H19O12- (463.08764740000004)


   

(E)-3-(2,4-dichlorophenyl)-N-[(3R)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]prop-2-enamide

(E)-3-(2,4-dichlorophenyl)-N-[(3R)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]prop-2-enamide

C25H19Cl2N3O2 (463.0854254)


D002317 - Cardiovascular Agents > D026902 - Potassium Channel Blockers D049990 - Membrane Transport Modulators

   

N(6)-(1,2-dicarboxyethyl)-AMP

N(6)-(1,2-dicarboxyethyl)-AMP

C14H18N5O11P (463.0740408)


The N(6)-(1,2-dicarboxyethyl) derivative of adenosine 5-monophosphate.

   

myricitrin(1-)

myricitrin(1-)

C21H19O12 (463.08764740000004)


A flavonoid oxoanion that is the conjugate base of myricitrin arising from selective deprotonation of the 7-hydroxy group; major species at pH 7.3.

   

quercetin 3-O-beta-D-glucopyranoside(1-)

quercetin 3-O-beta-D-glucopyranoside(1-)

C21H19O12 (463.08764740000004)


A flavonoid oxoanion resulting from the deprotonation of the hydroxy group at position 7 of the flavone moiety of quercetin. The major species at pH 7.3.

   

4-hydroxyglucobrassicin(1-)

4-hydroxyglucobrassicin(1-)

C16H19N2O10S2 (463.0481094)


An indolylmethylglucosinolate that is the conjugate base of 4-hydroxyglucobrassicin.

   

6-({2,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(sulfooxy)oxan-4-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-({2,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(sulfooxy)oxan-4-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C13H21NO15S (463.06318760000005)